| Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence A Takaoka, S Hayakawa, H Yanai, D Stoiber, H Negishi, H Kikuchi, ... Nature 424 (6948), 516, 2003 | 852 | 2003 |
| Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ D Stoiber, P Kovarik, S Cohney, JA Johnston, P Steinlein, T Decker The Journal of Immunology 163 (5), 2640-2647, 1999 | 293 | 1999 |
| Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway P Kovarik, D Stoiber, PA Eyers, R Menghini, A Neininger, M Gaestel, ... Proceedings of the National Academy of Sciences 96 (24), 13956-13961, 1999 | 282 | 1999 |
| Stat1 combines signals derived from IFN‐γ and LPS receptors during macrophage activation P Kovarik, D Stoiber, M Novy, T Decker The EMBO journal 17 (13), 3660-3668, 1998 | 240 | 1998 |
| Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. A Meinke, F Barahmand-Pour, S Wöhrl, D Stoiber, T Decker Molecular and cellular biology 16 (12), 6937-6944, 1996 | 179 | 1996 |
| Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes S Stockinger, T Materna, D Stoiber, L Bayr, R Steinborn, T Kolbe, H Unger, ... The Journal of Immunology 169 (11), 6522-6529, 2002 | 172 | 2002 |
| A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development E Eckelhart, W Warsch, E Zebedin, O Simma, D Stoiber, T Kolbe, ... Blood 117 (5), 1565-1573, 2011 | 131 | 2011 |
| STAT1 acts as a tumor promoter for leukemia development B Kovacic, D Stoiber, R Moriggl, E Weisz, RG Ott, R Kreibich, DE Levy, ... Cancer cell 10 (1), 77-87, 2006 | 128 | 2006 |
| Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3 D Stoiber, S Stockinger, P Steinlein, J Kovarik, T Decker The Journal of Immunology 166 (1), 466-472, 2001 | 98 | 2001 |
| TYK2 is a key regulator of the surveillance of B lymphoid tumors D Stoiber, B Kovacic, C Schuster, C Schellack, M Karaghiosoff, R Kreibich, ... The Journal of clinical investigation 114 (11), 1650-1658, 2004 | 86 | 2004 |
| Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis B Grabner, D Schramek, KM Mueller, HP Moll, J Svinka, T Hoffmann, ... Nature communications 6, 6285, 2015 | 79 | 2015 |
| Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity B Strobl, D Stoiber, V Sexl, M Mueller Front Biosci 16, 3214-32, 2011 | 57 | 2011 |
| Type I interferon signaling prevents IL-1β-driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue V Castiglia, A Piersigilli, F Ebner, M Janos, O Goldmann, U Damböck, ... Cell host & microbe 19 (3), 375-387, 2016 | 42 | 2016 |
| Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection E Kernbauer, V Maier, D Stoiber, B Strobl, C Schneckenleithner, V Sexl, ... PLoS pathogens 8 (6), e1002763, 2012 | 42 | 2012 |
| Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma N Rohr‐Udilova, W Sieghart, R Eferl, D Stoiber, L Björkhem‐Bergman, ... Hepatology 55 (4), 1112-1121, 2012 | 40 | 2012 |
| Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL A Pilz, W Kratky, S Stockinger, O Simma, U Kalinke, K Lingnau, ... The Journal of Immunology 183 (4), 2286-2293, 2009 | 39 | 2009 |
| Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts G Fuka, HP Kantner, R Grausenburger, A Inthal, E Bauer, G Krapf, ... Leukemia 26 (5), 927, 2012 | 38 | 2012 |
| Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias C Schneckenleithner, Z Bago-Horvath, H Dolznig, N Neugebauer, ... Oncotarget 2 (12), 1043, 2011 | 38 | 2011 |
| Leukemic challenge unmasks a requirement for PI3Kδ in NK cell–mediated tumor surveillance E Zebedin, O Simma, C Schuster, EM Putz, S Fajmann, W Warsch, ... Blood 112 (12), 4655-4664, 2008 | 37 | 2008 |
| Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation V Sexl, B Kovacic, R Piekorz, R Moriggl, D Stoiber, A Hoffmeyer, ... Blood 101 (12), 4937-4943, 2003 | 36 | 2003 |